웹2024년 1월 25일 · [바이오타임즈] 한국제약바이오협회(회장 원희목)는 국내 제약사들의 유럽 시장 진출 교두보를 마련하기 위해 지난 24일 서울 종로구 주한 스위스대사관에서 스위스 바젤 … 웹Welcome to BaseLaunch. We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. And we know how … BaseLaunch is deeply embedded within this ecosystem, while also being connected … We help launch and build ventures to the point where they can complete a Series … We have a broad portfolio covering a wide range of therapeutic areas, and across … BaseLaunch Portfolio has raised over half a billion dollars to date! Portfolio news. … Our partners include some of the top life science companies! These include … We are looking for breakthrough innovations that can form the basis of … Sector: Exclusively therapeutics. We do not support medical device, e-health or … Basel Area Business & Innovation: Dufourstrasse 11, 4010 Basel, …
Bridge Biotherapeutics becomes partner of BaseLaunch biotech …
웹1일 전 · Insgesamt 105 Millionen Dollar fliessen bald auf das Konto von Alentis. Das Geld kommt aber nicht von BaseLaunch, sondern von mehreren Investoren aus dem Pharmabereich, die in das Projekt investieren. 웹Stephan is Director of Business Development & Operations and also heads Therapeutics Innovation at Basel Area Business and Innovation. He has been deeply involved in … twl2.2
Interest from startups in the BaseLaunch healthcare accelerator …
웹2024년 6월 28일 · BaseLaunch has supported the first companies in 2024, and our portfolio has raised more than USD 270 Million in financing to date. Two new companies have been … 웹2024년 3월 22일 · BaseLaunch incubates and accelerates early-stage therapeutics ventures. Since early 2024, BaseLaunch has backed nine ventures. They have collectively raised … 웹2024년 3월 14일 · Swiss Healthcare Licensing group is happy to announce the Swiss Healthcare Start- up Partnering Initiative.An educational program for early-stage healthcare … talent pass extension after years